AVIENCE BIOMEDICALS LTD (AVIENCE-SM): AVIENCE BIOMEDICALS Share Price Rises 8.31% Today to Rs 316.80
- September 9, 2026
- Posted by: Harsh Piplani
- Category: News
AVIENCE BIOMEDICALS Share Price moved higher today, with the stock last traded at Rs 316.80, up 8.31% from the previous close of Rs 292.50. The company’s market capitalisation stood at Rs 150.29 Cr, placing this move in the context of a small-cap healthcare name that is drawing active stock-market attention. According to latest Univest data, the price event is confirmed, while a company-specific catalyst is not established by the available market snapshot.
The latest Univest figures show AVIENCE BIOMEDICALS trading between Rs 302 and Rs 320 after opening at Rs 302.00. That makes today’s move relevant for traders following AVIENCE BIOMEDICALS Share Price Today, AVIENCE BIOMEDICALS Stock News and AVIENCE BIOMEDICALS Share Price Rise searches. From Univest’s perspective, the key question is whether this is a short-lived price action move or part of a broader rerating supported by fundamentals, sector positioning and relative valuation.
AVIENCE BIOMEDICALS Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 316.8 |
| Previous Close | Rs 292.5 |
| Today's Move | Rs 24.3 (+8.31%) |
| Open | Rs 302 |
| High | Rs 320 |
| Low | Rs 302 |
| Turnover | Rs 0.95 crore |
| Market Capitalisation | Rs 150.29 crore |
| Market Cap Category | Micro Cap |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) rose to Rs 316.8 from the previous close of Rs 292.5, a move of Rs 24.3 or 8.31%. The stock opened at Rs 302, reached a high of Rs 320, recorded a low of Rs 302.
AVIENCE BIOMEDICALS Share Price Today showed a clear upward move, rising Rs 24.30 from the previous close to Rs 316.80. The stock opened at Rs 302.00, touched a high of Rs 320.00 and a low of Rs 302.00, which keeps the day’s price action tightly contained around the opening level while finishing well above the prior mark. Turnover stood at Rs 0.95 Cr, giving investors a sense of the activity around the move without adding any company-specific catalyst. For readers tracking AVIENCE BIOMEDICALS Stock News, the key fact is simple: the share price rise is real, measurable and significant for a stock with a market cap of Rs 150.29 Cr.
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 150.29 crore |
| P/E Ratio | 18.33x |
| P/B Ratio | 6.62x |
| ROE | 49.9% |
| ROCE | 34.16% |
| EPS | Rs 15.96 |
| Book Value Per Share | Rs 44.18 |
| Dividend Yield | 0% |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) fundamental metrics show P/E 18.33x, P/B 6.62x, ROE 49.9%, ROCE 34.16%. These figures provide context only and are not a buy or sell signal.
AVIENCE BIOMEDICALS LTD has a market capitalisation of Rs 150.29 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 18.33x, P/B at 6.62x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 49.9% and ROCE of 34.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.96, book value per share of Rs 44.18, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.82x, median ROE of 14%, median ROCE of 16.41%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Medical Equipment/Supplies/Accessories |
| Benchmark Scope | same industry |
| Company P/E Ratio | 18.33x |
| Benchmark Median P/E | 30.82x |
| Benchmark Average P/E | 88.09x |
| Benchmark P/E Range | 7.52x to 1,004.34x |
| Company P/B Ratio | 6.62x |
| Benchmark Median P/B | 3.54x |
| Company ROE | 49.9% |
| Benchmark Median ROE | 14% |
| Company ROCE | 34.16% |
| Benchmark Median ROCE | 16.41% |
| Company Market Capitalisation | Rs 150.29 crore |
| Benchmark Median Market Cap | Rs 161.43 crore |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a P/E ratio of 18.33x, which is below the benchmark median of 30.82x, a difference of -40.53%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a ROE of 49.9%, which is above the benchmark median of 14%, a difference of +256.43%. AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a ROCE of 34.16%, which is above the benchmark median of 16.41%, a difference of +108.17%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| LENSKART SOLUTIONS LTD | LENSKART | 1,19,664.26 | 184.65 | 13.53 | 6.85 | 12.55 |
| Poly Medicure Ltd. | POLYMED | 17,240.06 | 55.66 | 5.51 | 10.94 | 14.05 |
| Q-LINE BIOTECH LIMITED | QLINE | 1,460.93 | 26.13 | 6.88 | 13.94 | 19.19 |
| 3B Blackbio Dx Ltd. | 3BBLACKBIO | 1,306.02 | 22.53 | 4.47 | 19.41 | 26.03 |
| LAXMI DENTAL LIMITED | LAXMIDENTL | 1,089.03 | 35.46 | 4.33 | 21.4 | 24.97 |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a P/E ratio of 18.33x compared with the displayed peer median of 35.46x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 49.9% compares with a peer median of 13.94% across the companies shown in the table. ROCE stood at 34.16% versus the displayed peer median of 19.19%, providing a capital-efficiency comparison. AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a market capitalisation of Rs 150.29 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching AVIENCE BIOMEDICALS
- The share price rose 8.31% to Rs 316.80, which makes AVIENCE BIOMEDICALS Stock Gaining Today a visible market event.
- Market cap of Rs 150.29 Cr places the stock in a size category where valuation changes can matter quickly.
- P/E of 18.33 is below the industry median of 30.82, which keeps AVIENCE BIOMEDICALS Share Price interesting on relative earnings pricing.
- ROE of 49.9% and ROCE of 34.16% are materially above the same-industry benchmark.
- Univest data confirms the move but does not establish a company-specific catalyst, so investors are likely watching for follow-through in price action.
About AVIENCE BIOMEDICALS
AVIENCE BIOMEDICALS LTD operates in the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. Based on that industry tag, the business sits within a segment that serves healthcare users through equipment, supplies and related accessories rather than broad pharmaceutical distribution. That positioning matters because the sector tends to be assessed through a mix of earnings quality, balance-sheet strength and pricing discipline.
For readers following AVIENCE BIOMEDICALS Share Price, the company’s appeal today comes from a combination of a small market cap, strong return ratios and a valuation that is lower than many higher-multiple peers on P/E. The company’s EPS of Rs 15.96 and book value of Rs 44.18 add further context to how the market may be pricing the stock. In Univest terms, AVIENCE BIOMEDICALS Share Price Today is a stock-market story first, but it is also a business-quality story.
Frequently Asked Questions
Why did AVIENCE BIOMEDICALS Share Price rise today?
Ans. AVIENCE BIOMEDICALS Share Price rose 8.31% today to Rs 316.80, but the latest Univest data does not establish a company-specific catalyst. The move is confirmed by market pricing and turnover.
What is AVIENCE BIOMEDICALS Share Price today?
Ans. AVIENCE BIOMEDICALS Share Price today is Rs 316.80, compared with the previous close of Rs 292.50. That places the stock firmly among today’s notable small-cap healthcare movers. The stock moved 8.31% so far today.
How much did AVIENCE BIOMEDICALS Share Price gain?
Ans. AVIENCE BIOMEDICALS Share Price gained Rs 24.30, or 8.31%, in today’s market action. The stock also moved from an opening level of Rs 302.00 to a high of Rs 320.00.
What is the market capitalisation of AVIENCE BIOMEDICALS?
Ans. AVIENCE BIOMEDICALS has a market capitalisation of Rs 150.29 Cr. That keeps it in the small-cap category and helps explain why price changes can look sharp on a percentage basis.
What valuation does AVIENCE BIOMEDICALS Share Price imply?
Ans. AVIENCE BIOMEDICALS Share Price reflects a P/E of 18.33 and a P/B of 6.62. The P/E is below the industry median, while the P/B is above the sector median.
How does AVIENCE BIOMEDICALS compare with healthcare peers?
Ans. Compared with peers in the same industry, AVIENCE BIOMEDICALS has a lower P/E than several listed names and stronger ROE and ROCE. That combination helps it stand out in peer comparison.
What do EPS and book value tell investors about AVIENCE BIOMEDICALS?
Ans. AVIENCE BIOMEDICALS reports EPS of Rs 15.96 and book value of Rs 44.18. EPS shows earnings attributable to each share, while book value reflects accounting net worth per share.
How should readers track AVIENCE BIOMEDICALS Share Price on Univest?
Ans. Readers can follow AVIENCE BIOMEDICALS Share Price on Univest for live prices, valuation ratios, sector context, market cap, and 52-week levels. That makes it easier to monitor price action in one place.
Track AVIENCE BIOMEDICALS Share Price on Univest
Use AVIENCE BIOMEDICALS LTD (AVIENCE-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track AVIENCE BIOMEDICALS Share Price on Univest for live share price updates, fundamental ratios, valuation context, sector comparison, 52-week levels and market insights. Univest also helps readers follow AVIENCE BIOMEDICALS Stock News, AVIENCE BIOMEDICALS Latest News and AVIENCE BIOMEDICALS Share Price Update in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
